Abstract

Background and Objectives: The purpose of this study is to present the clinical results over a 12-month follow-up period in patients after simultaneous bilateral crystalline lens removal with implantation of a Tecnis Eyhance DIB00 monofocal plus lens. Materials and Methods: This is a single-center, 12-month, retrospective study involving 214 eyes of 107 patients operated on between 2021 and 2023. Measurements included uncorrected and best-corrected visual acuity at 30 cm, 70 cm, and distance vision under fixed lighting conditions, instead of focusing on patient-dependent factors, such as pupil size, which varies individually based on sympathetic and parasympathetic nervous systems balance, simulating visual performance in real-world conditions. Contrast sensitivity was also assessed at 6 and 12 months postoperatively. Patients filled out a questionnaire on quality of life after surgery. Results: Uncorrected and best-corrected visual acuity were, respectively, for a 30 cm distance UCVA 0.76/BCVA 0.18 LogMAR; for a 70 cm distance UCVA 0.03/BCVA −0.036 LogMAR; and for distance vision UCVA 0.05/BCVA 0.02. None of the patients reported adverse phenomena such as halo, glare, contrast decrease, or other phenomena after surgery. The average rating of patient satisfaction assessed in a special questionnaire was 8.54 out of 10 points. Conclusions: The Tecnis Eyhance DIB00 lens implanted during bilateral cataract surgery produced good results in terms of uncorrected visual acuity under various lighting conditions, which in our population was better than predicted by the lens manufacturer. Through the 12-month observation period, postoperative refractive values remained stable, with no deterioration of vision.

IPC Classification

Keywords